Barrington Research Maintains Outperform on ModivCare, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky maintains an Outperform rating on ModivCare (NASDAQ:MODV) and raises the price target from $19 to $22.
October 03, 2024 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research has reaffirmed its Outperform rating for ModivCare and increased the price target from $19 to $22, indicating a positive outlook.
The reaffirmation of an Outperform rating and an increased price target from a reputable analyst can boost investor confidence and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100